<?xml version="1.0" encoding="UTF-8"?>
<p id="Par34">Following adoption of corticosteroids as a standard first line of therapy in acute viral croup, overall hospitalization and the burden of the disease on healthcare systems worldwide began to fall. This was acknowledged following the guidelines formulated by the Canadian Pediatric Society that encouraged the use of intravenous dexamethasone as initial treatment of croup [
 <xref ref-type="bibr" rid="CR9">9</xref>]. Among steroids, dexamethasone is used in a dose of 0.6 mg · Kg
 <sup>−1</sup> body weight given either orally or by the intramuscular route. As dexamethasone is a potent steroid with a prolonged half-life, repeat doses are often unnecessary.
</p>
